Catalyst Pharmaceuticals Inc (CPRX) — Long-term Investment Intensity
Catalyst Pharmaceuticals Inc (CPRX) has a Long-term Investment Intensity of 2.4% as of March 2026. Long-term investments of $27.29 Million represent 2.4% of total assets of $1.15 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Catalyst Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Catalyst Pharmaceuticals Inc Long-term Investment Intensity (2018–2025)
This chart shows how Catalyst Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2018 to 2025. As of March 2026, the intensity stands at 2.4%, reflecting long-term investments of $27.29 Million against total assets of $1.15 Billion USD. For the complete balance sheet picture, see Catalyst Pharmaceuticals Inc assets under control.
Annual Long-term Investment Intensity for Catalyst Pharmaceuticals Inc (2018–2025)
The table below presents the year-by-year Long-term Investment Intensity for Catalyst Pharmaceuticals Inc from 2018 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read CPRX total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 2.0% | $22.54 Million | $1.11 Billion | ▼ -0.5 pp |
| 2024 | 2.5% | $21.56 Million | $851.41 Million | ▼ -1.0 pp |
| 2023 | 3.5% | $16.49 Million | $470.11 Million | ▼ -4.8 pp |
| 2018 | 8.3% | $5.01 Million | $60.45 Million | — |